Meta Biomed Co., Ltd. (KOSDAQ:059210)
South Korea · Delayed Price · Currency is KRW 3,935.00
+55.00 (1.42%)
At close: Jul 16, 2026
Meta Biomed Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 106,920 | 134,503 | 84,852 | 99,718 | 52,832 | 66,184 | |
Market Cap Growth | -26.29% | 58.52% | -14.91% | 88.74% | -20.17% | 2.85% |
Enterprise Value | 113,835 | 136,406 | 95,997 | 130,453 | 76,546 | 89,589 |
Last Close Price | 3935.00 | 4896.52 | 3575.27 | 4167.14 | 2197.23 | 2725.62 |
PE Ratio | 10.98 | 12.24 | 3.79 | 9.89 | 20.11 | 6.95 |
Forward PE | 5.84 | 6.08 | - | - | - | - |
PS Ratio | 1.07 | 1.31 | 0.90 | 1.20 | 0.77 | 1.13 |
PB Ratio | 0.84 | 1.08 | 0.88 | 1.37 | 0.83 | 1.10 |
P/TBV Ratio | 0.85 | 1.10 | 0.93 | 1.46 | 0.91 | 1.16 |
P/FCF Ratio | - | - | 7.24 | - | - | 7.30 |
P/OCF Ratio | 6.27 | 6.78 | 3.75 | 9.76 | 5.77 | 5.94 |
EV/Sales Ratio | 1.14 | 1.33 | 1.02 | 1.57 | 1.11 | 1.52 |
EV/EBITDA Ratio | 4.25 | 5.11 | 4.32 | 8.80 | 8.30 | 10.14 |
EV/EBIT Ratio | 5.41 | 6.44 | 5.57 | 12.30 | 14.27 | 17.03 |
EV/FCF Ratio | - | - | 8.19 | - | - | 9.88 |
Debt / Equity Ratio | 0.35 | 0.34 | 0.58 | 0.61 | 0.70 | 0.57 |
Debt / EBITDA Ratio | 1.69 | 1.60 | 2.53 | 3.00 | 4.78 | 3.90 |
Debt / FCF Ratio | - | - | 4.79 | - | - | 3.80 |
Net Debt / Equity Ratio | 0.05 | 0.04 | 0.02 | 0.38 | 0.39 | 0.31 |
Net Debt / EBITDA Ratio | 0.25 | 0.18 | 0.08 | 1.86 | 2.70 | 2.10 |
Net Debt / FCF Ratio | -4.62 | -10.31 | 0.16 | -21.74 | -4.00 | 2.05 |
Asset Turnover | 0.54 | 0.57 | 0.61 | 0.66 | 0.62 | 0.56 |
Inventory Turnover | 2.25 | 2.35 | 2.73 | 2.99 | 2.65 | 2.10 |
Quick Ratio | 1.08 | 0.97 | 0.94 | 0.71 | 0.75 | 0.76 |
Current Ratio | 1.55 | 1.39 | 1.28 | 1.12 | 1.14 | 1.20 |
Return on Equity (ROE) | 8.34% | 9.75% | 26.25% | 14.74% | 4.61% | 17.37% |
Return on Assets (ROA) | 6.94% | 7.28% | 7.00% | 5.28% | 2.99% | 3.12% |
Return on Invested Capital (ROIC) | 12.96% | 15.93% | 16.52% | 11.24% | 6.28% | 6.70% |
Return on Capital Employed (ROCE) | 15.10% | 16.70% | 16.60% | 12.40% | 7.00% | 8.10% |
Earnings Yield | 9.15% | 8.17% | 26.40% | 10.11% | 4.97% | 14.39% |
FCF Yield | -1.31% | -0.35% | 13.81% | -1.27% | -11.80% | 13.70% |
Dividend Yield | 2.67% | 2.14% | 0.84% | 0.48% | 0.91% | 0.73% |
Payout Ratio | - | 6.23% | 2.04% | 4.54% | 17.43% | 2.40% |
Buyback Yield / Dilution | 8.37% | 7.40% | -18.55% | 0.06% | 0.07% | 0.61% |
Total Shareholder Return | 11.04% | 9.54% | -17.71% | 0.54% | 0.98% | 1.34% |